Evidence map›Paper›PMID 32383039›Full record

ReviewCurrent gastroenterology reports2020

Management of Hepatolithiasis: Review of the Literature.

Eric Lorio, Pavan Patel, Laura Rosenkranz, Sandeep Patel, Hari Sayana

Abstract readReview
PubMed Publisher
In one paragraph

Review in Current gastroenterology reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Evolution of surgical treatment for hepatolithiasis.World journal of gastrointestinal surgery · 2024
    Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Eric LorioDepartment of Internal Medicine, UT Health San Antonio - Long School of Medicine, San Antonio, TX, 78229-3900, USA.
Pavan PatelDivision of Gastroenterology & Nutrition, Department of Medicine, UT Health San Antonio - Long School of Medicine, MC 7878, 7703 Floyd Curl Dr., San Antonio, TX, 78229-3900, USA.
Laura RosenkranzDivision of Gastroenterology & Nutrition, Department of Medicine, UT Health San Antonio - Long School of Medicine, MC 7878, 7703 Floyd Curl Dr., San Antonio, TX, 78229-3900, USA.
Sandeep PatelDivision of Gastroenterology & Nutrition, Department of Medicine, UT Health San Antonio - Long School of Medicine, MC 7878, 7703 Floyd Curl Dr., San Antonio, TX, 78229-3900, USA.
Hari SayanaDivision of Gastroenterology & Nutrition, Department of Medicine, UT Health San Antonio - Long School of Medicine, MC 7878, 7703 Floyd Curl Dr., San Antonio, TX, 78229-3900, USA. Sayana@uthscsa.edu.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purpose of reviewHepatolithiasis is a disease characterized by intrahepatic stone formation. In this article, we review the features of this disease and explore the established and emerging treatment modalities. RECENT

findingsRecent reports show an increasing prevalence of hepatolithiasis, likely owed to increased immigration and shifts in the Western diet. New pharmacotherapy options are limited and are often only supportive. Endoscopic intervention still cruxes on removal of impacted stones, though new techniques such as bile duct exploratory lithotomy and lithotripsy continue to advance management. Although hepatectomy of the effected portion of the liver offers definitive therapy, alternative less invasive modalities such as combined endoscopic/interventional radiology modalities have been utilized in select patients. Additionally, liver transplant serves as an option for otherwise incurable hepatolithiasis with coexisting liver dysfunction. Multiple emerging pharmacologic and procedural interventions may provide novel treatment for hepatolithiasis. While definitive therapy remains resection of affected liver segments, these modalities offer hope for less invasive approaches in the future.

Indexed as

Bile Ducts, IntrahepaticCholelithiasisHumansLiver DiseasesPrognosisTreatment OutcomeCholangiohepatitisHepatolithiasisIntrahepatic stonesRecurrent cholangitis

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.